Prescription-only sterile enzymatic debriding ointment, containing 250 collagenase units per gram of white petrolatum USP, designed for the effective removal of necrotic tissue.
Specifically indicated for the debridement of chronic dermal ulcers, promoting faster healing by continuously removing non-viable tissue at the microscopic level.
SANTYL® Ointment is FDA approved for active enzymatic therapy, suitable for use in both initial and continuous debridement phases, even after sharp or surgical methods.
Formulated by Smith & Nephew, this ointment is a critical tool in wound care management, ensuring a clean wound bed for optimal healing.
